Showing results (2391-2400 of 9,904) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|February 8, 2024
Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party studyOlga Moser, Maud Ngoya, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation|February 6, 2024
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantationSofia Oechsler, Nico Gagelmann, Christine Wolschke, et al.
Bone Marrow Transplantation|February 24, 2024
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host diseaseAlistair Murray, Swe Mar Linn, Benoit Yu, et al.
Bone Marrow Transplantation|March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in GermanySandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Bone Marrow Transplantation|February 24, 2024
Remuneration of donors for cell and gene therapies: an update on the principles and perspective of the World Marrow Donor AssociationLina Hamad, Salmah Mahmood Ahmed, Eefke van Eerden, et al.
Bone Marrow Transplantation|February 26, 2024
Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trialMaría E Martínez-Muñoz, Concepción Payares-Herrera, Inés Lipperheide, et al.
Bone Marrow Transplantation|February 21, 2024
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHDLev Gorfinkel, Sharmila Raghunandan, Benjamin Watkins, et al.
Bone Marrow Transplantation|February 16, 2024
Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use programThirupathi Pattipaka, Séverine Sarp, Peyman Nakhaei, et al.
Bone Marrow Transplantation|January 31, 2024
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMTMeral Beksac, Diderik-Jan Eikema, Linda Koster, et al.
Bone Marrow Transplantation|August 10, 2023
Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioningShanze Arshad, Xi Fang, Kwang W Ahn, et al.
Pageof 991